225 related articles for article (PubMed ID: 28779025)
1. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Alberts R; de Vries EMG; Goode EC; Jiang X; Sampaziotis F; Rombouts K; Böttcher K; Folseraas T; Weismüller TJ; Mason AL; Wang W; Alexander G; Alvaro D; Bergquist A; Björkström NK; Beuers U; Björnsson E; Boberg KM; Bowlus CL; Bragazzi MC; Carbone M; Chazouillères O; Cheung A; Dalekos G; Eaton J; Eksteen B; Ellinghaus D; Färkkilä M; Festen EAM; Floreani A; Franceschet I; Gotthardt DN; Hirschfield GM; Hoek BV; Holm K; Hohenester S; Hov JR; Imhann F; Invernizzi P; Juran BD; Lenzen H; Lieb W; Liu JZ; Marschall HU; Marzioni M; Melum E; Milkiewicz P; Müller T; Pares A; Rupp C; Rust C; Sandford RN; Schramm C; Schreiber S; Schrumpf E; Silverberg MS; Srivastava B; Sterneck M; Teufel A; Vallier L; Verheij J; Vila AV; Vries B; Zachou K; ; Chapman RW; Manns MP; Pinzani M; Rushbrook SM; Lazaridis KN; Franke A; Anderson CA; Karlsen TH; Ponsioen CY; Weersma RK
Gut; 2018 Aug; 67(8):1517-1524. PubMed ID: 28779025
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.
Juran BD; Atkinson EJ; Schlicht EM; Larson JJ; Ellinghaus D; Franke A; Lazaridis KN
Liver Int; 2011 Jul; 31(6):785-91. PubMed ID: 21134112
[TBL] [Abstract][Full Text] [Related]
3. Search for Genetic Modifiers of PSC: Time to Increase the Number of Needles in the Haystack.
Krawczyk M; Lammert F
Ann Hepatol; 2017 November-December,; 16(6):830-831. PubMed ID: 29055915
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
5. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
[TBL] [Abstract][Full Text] [Related]
7. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
8. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
10. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
[TBL] [Abstract][Full Text] [Related]
11. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of two functional CD24 polymorphisms in primary sclerosing cholangitis.
Zhang CC; Voitl R; Hippchen T; Weiss KH; Sauer P; Rupp C
Scand J Gastroenterol; 2020 May; 55(5):581-587. PubMed ID: 32329406
[No Abstract] [Full Text] [Related]
13. MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.
Korkmaz KS; de Rooij BJ; van Hoek B; Janse M; Coenraad MJ; van der Reijden JJ; Weersma RK; Porte RJ; Voorneveld PW; Baranski AG; Verspaget HW
Liver Int; 2014 Feb; 34(2):274-80. PubMed ID: 23809662
[TBL] [Abstract][Full Text] [Related]
14. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.
Halliday JS; Djordjevic J; Lust M; Culver EL; Braden B; Travis SP; Chapman RW
J Crohns Colitis; 2012 Mar; 6(2):174-81. PubMed ID: 22325171
[TBL] [Abstract][Full Text] [Related]
15. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
16. The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
Freund C; Wahlers A; Begli NH; Leopold Y; Klöters-Plachky P; Mehrabi A; Mohr I; Sander J; Rupp C; Gotthardt DN; Weiss KH
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):646-652. PubMed ID: 31928970
[TBL] [Abstract][Full Text] [Related]
17. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
Liu JZ; Hov JR; Folseraas T; Ellinghaus E; Rushbrook SM; Doncheva NT; Andreassen OA; Weersma RK; Weismüller TJ; Eksteen B; Invernizzi P; Hirschfield GM; Gotthardt DN; Pares A; Ellinghaus D; Shah T; Juran BD; Milkiewicz P; Rust C; Schramm C; Müller T; Srivastava B; Dalekos G; Nöthen MM; Herms S; Winkelmann J; Mitrovic M; Braun F; Ponsioen CY; Croucher PJ; Sterneck M; Teufel A; Mason AL; Saarela J; Leppa V; Dorfman R; Alvaro D; Floreani A; Onengut-Gumuscu S; Rich SS; Thompson WK; Schork AJ; Næss S; Thomsen I; Mayr G; König IR; Hveem K; Cleynen I; Gutierrez-Achury J; Ricaño-Ponce I; van Heel D; Björnsson E; Sandford RN; Durie PR; Melum E; Vatn MH; Silverberg MS; Duerr RH; Padyukov L; Brand S; Sans M; Annese V; Achkar JP; Boberg KM; Marschall HU; Chazouillères O; Bowlus CL; Wijmenga C; Schrumpf E; Vermeire S; Albrecht M; ; Rioux JD; Alexander G; Bergquist A; Cho J; Schreiber S; Manns MP; Färkkilä M; Dale AM; Chapman RW; Lazaridis KN; ; Franke A; Anderson CA; Karlsen TH;
Nat Genet; 2013 Jun; 45(6):670-5. PubMed ID: 23603763
[TBL] [Abstract][Full Text] [Related]
18. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
19. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
[TBL] [Abstract][Full Text] [Related]
20. Small-duct primary sclerosing cholangitis: a long-term follow-up study.
Angulo P; Maor-Kendler Y; Lindor KD
Hepatology; 2002 Jun; 35(6):1494-500. PubMed ID: 12029635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
